The mDFS of CRC patients with high CTC-TRPC5 level was significantly lower than those with low or no TRPC5 expression, and multivariate analysis showed that high CTC-TRPC5 was an independent poor prognostic factor that affected the prognosis. Here, TRPC5 is linked to colorectal carcinoma.